United States · Series B startup

Who invested in Nuvalent, Inc.

One round we have observed, with the 12 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$135Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $135MMay 2021
Led by
Bain Capital Life Sciences
Investors
12 (1 led)
See who backed them

The rounds

  1. May 2021

Everyone who backed them

Bain Capital Life SciencesPrivate equity1round, led 1
DeerfieldVC firm1round
Janus Henderson InvestorsPrivate equity1round
Viking GlobalVC firm1round
Logos CapitalVC firm1round
Avoro Capital AdvisorsGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Nuvalent, Inc.

Who invested in Nuvalent, Inc.?

Nuvalent, Inc.'s investors include Bain Capital Life Sciences, Wellington Management, Deerfield, Janus Henderson Investors and Viking Global, and 7 more on record. Bain Capital Life Sciences led its latest round.

How much has Nuvalent, Inc. raised?

Nuvalent, Inc. has raised $135M across 1 round since 2021.

When did Nuvalent, Inc. last raise?

Nuvalent, Inc.'s most recent round was a Series B of $135M in May 2021, led by Bain Capital Life Sciences.

What was Nuvalent, Inc.'s biggest round?

Its most recent round, $135M in May 2021, is also its largest on record.

Who backed Nuvalent, Inc. first?

Nuvalent, Inc.'s first round on record, in May 2021, was backed by Bain Capital Life Sciences, Wellington Management and Deerfield and 9 others.

What stage is Nuvalent, Inc. at?

Nuvalent, Inc.'s latest named round is a Series B, in May 2021.

Where is Nuvalent, Inc. based?

Nuvalent, Inc. is based in the United States.

Who led Nuvalent, Inc.'s rounds?

Bain Capital Life Sciences led the Series B in 2021.

Companies like Nuvalent, Inc.

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.